Cargando…

Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway

Background: The incidence of breast cancer (BC) worldwide has increased substantially in recent years. Epithelial-mesenchymal transition (EMT) refers to a crucial event impacting tumor heterogeneity. Although cinobufagin acts as an effective anticancer agent, the clinical use of cinobufagin is limit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Yufeng, Wu, Haodong, Zhu, Tianru, Liu, Zitian, Liu, Conghui, Yan, Congzhi, Wu, Zhixuan, Xu, Yiying, Bai, Ying, Yang, Lehe, Cheng, Dezhi, Zhang, Xiaohua, Zhao, Haiyang, Zhao, Chengguang, Dai, Xuanxuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497018/ https://www.ncbi.nlm.nih.gov/pubmed/37651362 http://dx.doi.org/10.18632/aging.204967

Ejemplares similares

Cinobufagin exerts an antitumor effect in non-small-cell lung cancer by blocking STAT3 signaling
por: Yan, Sunshun, et al.
Publicado: (2023)

Downstream Neighbor of Son Overexpression is Associated With Breast Cancer Progression and a Poor Prognosis
por: Qi, Yufeng, et al.
Publicado: (2022)

Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway
por: Yang, Lehe, et al.
Publicado: (2020)

A Novel Approach: Combining Prognostic Models and Network Pharmacology to Target Breast Cancer Necroptosis-Associated Genes
por: Yan, Congzhi, et al.
Publicado: (2022)

Osthole inhibits triple negative breast cancer cells by suppressing STAT3
por: Dai, Xuanxuan, et al.
Publicado: (2018)

Pharmacological Effects of Cinobufagin
por: Zhang, Hao, et al.
Publicado: (2023)

Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2020)

Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis
por: Zheng, Dandan, et al.
Publicado: (2021)

Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway
por: Zhang, Chuan, et al.
Publicado: (2019)

Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2019)

Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2019)

L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway
por: Bai, Encheng, et al.
Publicado: (2018)

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
por: Lin, Shichong, et al.
Publicado: (2019)

Rhein sensitizes human colorectal cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
por: Zhuang, Yan, et al.
Publicado: (2019)

Flubendazole Elicits Antitumor Effects by Inhibiting STAT3 and Activating Autophagy in Non-small Cell Lung Cancer
por: Xie, Xiaona, et al.
Publicado: (2021)

Immunomodulatory Effects of Cinobufagin on Murine Lymphocytes and Macrophages
por: Yu, Yang, et al.
Publicado: (2015)

Cinobufagin Suppresses the Characteristics of Osteosarcoma Cancer Cells by Inhibiting the IL-6-OPN-STAT3 Pathway [Retraction]
Publicado: (2021)

Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Li, Xiaohe, et al.
Publicado: (2019)

Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer
por: Zhao, Zhucheng, et al.
Publicado: (2022)

Spatial Lipidomics Reveals Anticancer Mechanisms of Bufalin in Combination with Cinobufagin in Tumor-Bearing Mice
por: Zhang, Jinghui, et al.
Publicado: (2021)

Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1
por: Kim, Geon-Hee, et al.
Publicado: (2020)

Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
por: Shi, Lingyi, et al.
Publicado: (2017)

Prognostic value analysis of cholesterol and cholesterol homeostasis related genes in breast cancer by Mendelian randomization and multi-omics machine learning
por: Wu, Haodong, et al.
Publicado: (2023)

Resibufogenin and Cinobufagin Activate Central Neurons through an Ouabain-Like Action
por: Wang, Ze-Jun, et al.
Publicado: (2014)

Cinobufagin Modulates Human Innate Immune Responses and Triggers Antibacterial Activity
por: Xie, Shanshan, et al.
Publicado: (2016)

Preclinical study of cinobufagin as a promising anti-colorectal cancer agent
por: Lu, Xing-sheng, et al.
Publicado: (2016)

The synergistic antitumor effect of cinobufagin and cisplatin in human osteosarcoma cell line in vitro and in vivo
por: Dai, Guo, et al.
Publicado: (2017)

Cinobufagin Is a Selective Anti-Cancer Agent against Tumors with EGFR Amplification and PTEN Deletion
por: He, Kunyan, et al.
Publicado: (2021)

Cinobufagin suppresses colorectal cancer angiogenesis by disrupting the endothelial mammalian target of rapamycin/hypoxia‐inducible factor 1α axis
por: Li, Xiaowu, et al.
Publicado: (2019)

The anticancer effects of cinobufagin on hepatocellular carcinoma Huh-7 cells are associated with activation of the p73 signaling pathway
por: Zhao, Lei, et al.
Publicado: (2019)

Study of Cinobufagin as a Promising Anticancer Agent in Uveal Melanoma Through Intrinsic Apoptosis Pathway
por: Zhang, Leilei, et al.
Publicado: (2020)

Cinobufagin inhibits tumor growth by inducing apoptosis through Notch signaling pathways in human cholangiocarcinoma
por: Ren, Jiajun, et al.
Publicado: (2019)

PB2385: CINOBUFAGIN PROMOTES APOPTOSIS OF DIFFUSE LARGE B LYMPHOMA CELLS BY INHIBITING UBIQUITINATION DEGRADATION OF TP53
por: He, Sanxiu, et al.
Publicado: (2023)

Inhibitory Effect of Cinobufagin on L-Type Ca(2+) Currents, Contractility, and Ca(2+) Homeostasis of Isolated Adult Rat Ventricular Myocytes
por: Li, Pinya, et al.
Publicado: (2014)

Cinobufagin Induces Cell Cycle Arrest at the G2/M Phase and Promotes Apoptosis in Malignant Melanoma Cells
por: Pan, Zhaohai, et al.
Publicado: (2019)

Cinobufagin alleviates lipopolysaccharide-induced acute lung injury by regulating autophagy through activation of the p53/mTOR pathway
por: Wang, Cheng, et al.
Publicado: (2022)

Cinobufagin-Loaded and Folic Acid-Modified Polydopamine Nanomedicine Combined With Photothermal Therapy for the Treatment of Lung Cancer
por: Li, Jianwen, et al.
Publicado: (2021)

Cinobufagin Exerts Anticancer Activity in Oral Squamous Cell Carcinoma Cells through Downregulation of ANO1
por: Jo, Sungwoo, et al.
Publicado: (2021)

Alantolactone promotes ER stress‐mediated apoptosis by inhibition of TrxR1 in triple‐negative breast cancer cell lines and in a mouse model
por: Yin, Changtian, et al.
Publicado: (2019)

A Study on the Mechanism of Cinobufagin in the Treatment of Paw Cancer Pain by Modulating Local β-Endorphin Expression In Vivo
por: Chen, Tao, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qt7e842o49f6mpii4ij2gg8oq0